Literature DB >> 31654775

Central angiotensin II-Protein inhibitor of neuronal nitric oxide synthase (PIN) axis contribute to neurogenic hypertension.

Neeru M Sharma1, Andrea S Haibara2, Kenichi Katsurada3, Xuefei Liu3, Kaushik P Patel3.   

Abstract

Activation of renin-angiotensin- system, nitric oxide (NO•) bioavailability and subsequent sympathoexcitation plays a pivotal role in the pathogenesis of many cardiovascular diseases, including hypertension. Previously we have shown increased protein expression of PIN (a protein inhibitor of nNOS: neuronal nitric oxide synthase, known to dissociate nNOS dimers into monomers) with concomitantly reduced levels of catalytically active dimers of nNOS in the PVN of rats with heart failure. To elucidate the molecular mechanism by which Angiotensin II (Ang II) increases PIN expression, we used Sprague-Dawley rats (250-300 g) subjected to intracerebroventricular infusion of Ang II (20 ng/min, 0.5 μl/h) or saline as vehicle (Veh) for 14 days through osmotic mini-pumps and NG108-15 hybrid neuronal cell line treated with Ang II as an in vitro model. Ang II infusion significantly increased baseline renal sympathetic nerve activity and mean arterial pressure. Ang II infusion increased the expression of PIN (1.24 ± 0.04* Ang II vs. 0.65 ± 0.07 Veh) with a concomitant 50% decrease in dimeric nNOS and PIN-Ub conjugates (0.73 ± 0.04* Ang II vs. 1.00 ± 0.03 Veh) in the PVN. Substrate-dependent ligase assay in cells transfected with pCMV-(HA-Ub)8 vector revealed a reduction of HA-Ub-PIN conjugates after Ang II and a proteasome inhibitor, Lactacystin (LC), treatment (4.5 ± 0.7* LC Ang II vs. 9.2 ± 2.5 LC). TUBE (Tandem Ubiquitin-Binding Entities) assay showed decrease PIN-Ub conjugates in Ang II-treated cells (0.82 ± 0.12* LC Ang II vs. 1.21 ± 0.06 LC) while AT1R blocker, Losartan (Los) treatment diminished the Ang II-mediated stabilization of PIN (1.21 ± 0.07 LC Los vs. 1.16 ± 0.04* LC Ang II Los). Taken together, our studies suggest that increased central levels of Ang II contribute to the enhanced expression of PIN leading to reduced expression of the dimeric form of nNOS, thus diminishing the inhibitory action of NO• on pre-autonomic neurons in the PVN resulting in increased sympathetic outflow.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiotensin II; Neurogenic hypertension; Paraventricular nucleus; nNOS

Mesh:

Substances:

Year:  2019        PMID: 31654775      PMCID: PMC6911640          DOI: 10.1016/j.niox.2019.10.007

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  68 in total

Review 1.  The physiology and pathophysiology of nitric oxide in the brain.

Authors:  F X Guix; I Uribesalgo; M Coma; F J Muñoz
Journal:  Prog Neurobiol       Date:  2005-06       Impact factor: 11.685

Review 2.  Nitric oxide and synaptic function.

Authors:  E M Schuman; D V Madison
Journal:  Annu Rev Neurosci       Date:  1994       Impact factor: 12.449

3.  Angiotensin II blood-levels in human hypertension.

Authors:  K J Catt; E Cran; P Z Zimmet; J B Best; M D Cain; J P Coghlan
Journal:  Lancet       Date:  1971-03-06       Impact factor: 79.321

Review 4.  Nitric oxide in physiology and pathology.

Authors:  B J Whittle
Journal:  Histochem J       Date:  1995-10

5.  Renin and angiotensin: the complete system within the neuroblastoma x glioma cell.

Authors:  M C Fishman; E A Zimmerman; E E Slater
Journal:  Science       Date:  1981-11-20       Impact factor: 47.728

6.  Angiotensin II-mediated posttranslational modification of nNOS in the PVN of rats with CHF: role for PIN.

Authors:  Neeru M Sharma; Tamra L Llewellyn; Hong Zheng; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-05       Impact factor: 4.733

Review 7.  Blood pressure regulation in stress: focus on nitric oxide-dependent mechanisms.

Authors:  A Puzserova; I Bernatova
Journal:  Physiol Res       Date:  2016-10-24       Impact factor: 1.881

8.  Neuronal induction of the immunoproteasome in Huntington's disease.

Authors:  Miguel Díaz-Hernández; Félix Hernández; Ester Martín-Aparicio; Pilar Gómez-Ramos; María A Morán; José G Castaño; Isidro Ferrer; Jesús Avila; José J Lucas
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

9.  RNA silencing targeting PIN (protein inhibitor of neuronal nitric oxide synthase) attenuates the development of hypertension in young spontaneously hypertensive rats.

Authors:  Su-Chen Wang; Kuan-Miao Lin; Shao-Ju Chien; Li-Tung Huang; Chien-Ning Hsu; You-Lin Tain
Journal:  J Am Soc Hypertens       Date:  2013-09-12

10.  Hypothalamic paraventricular nucleus neuronal nitric oxide synthase activity is a major determinant of renal sympathetic discharge in conscious Wistar rats.

Authors:  F D McBryde; B H Liu; E V Roloff; S Kasparov; J F R Paton
Journal:  Exp Physiol       Date:  2018-01-19       Impact factor: 2.969

View more
  2 in total

1.  Central Ang II (Angiotensin II)-Mediated Sympathoexcitation: Role for HIF-1α (Hypoxia-Inducible Factor-1α) Facilitated Glutamatergic Tone in the Paraventricular Nucleus of the Hypothalamus.

Authors:  Neeru M Sharma; Andréa S Haibara; Kenichi Katsurada; Shyam S Nandi; Xuefei Liu; Hong Zheng; Kaushik P Patel
Journal:  Hypertension       Date:  2020-12-08       Impact factor: 10.190

2.  Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril.

Authors:  Kristina Repova; Peter Stanko; Tomas Baka; Kristina Krajcirovicova; Silvia Aziriova; Jaroslav Hrenak; Andrej Barta; Stefan Zorad; Russel J Reiter; Michaela Adamcova; Fedor Simko
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.